Pages that link to "Q55293734"
Jump to navigation
Jump to search
The following pages link to Stephen Man (Q55293734):
Displaying 41 items.
- Role of endogenous peptide in human alloreactive cytotoxic T cell responses (Q30311400) (← links)
- HCMV pUL135 remodels the actin cytoskeleton to impair immune recognition of infected cells (Q34116205) (← links)
- Clinical studies of human papilloma vaccines in pre-invasive and invasive cancer. (Q34189203) (← links)
- Immunology of human papillomavirus infection in lower genital tract neoplasia. (Q34374027) (← links)
- CD200 expression suppresses natural killer cell function and directly inhibits patient anti-tumor response in acute myeloid leukemia (Q34977414) (← links)
- Dendritic cell (DC) based therapy for cervical cancer: use of DC pulsed with tumour lysate and matured with a novel synthetic clinically non-toxic double stranded RNA analogue poly [I]:poly [C(12)U] (Ampligen R). (Q35047009) (← links)
- Human cellular immune responses against human papillomaviruses in cervical neoplasia. (Q35571065) (← links)
- CD8( ) T-cell recognition of a synthetic epitope formed by t-butyl modification (Q36019759) (← links)
- Cervical human papillomavirus infection and squamous intraepithelial lesions in rural Gambia, West Africa: viral sequence analysis and epidemiology (Q36615509) (← links)
- Cytomegalovirus infection does not impact on survival or time to first treatment in patients with chronic lymphocytic leukemia (Q37118775) (← links)
- CD8 T-cell specificity is compromised at a defined MHCI/CD8 affinity threshold (Q37560213) (← links)
- Decreased HPV-specific T cell responses and accumulation of immunosuppressive influences in oropharyngeal cancer patients following radical therapy (Q39328588) (← links)
- A novel tumor antigen derived from enhanced degradation of bax protein in human cancers. (Q39520036) (← links)
- HPV-16 E5 down-regulates expression of surface HLA class I and reduces recognition by CD8 T cells. (Q39660191) (← links)
- HPV16 E6 29-38-specific T cells kill cervical carcinoma cells despite partial evasion of T-cell effector function. (Q39998541) (← links)
- The nature of telomere fusion and a definition of the critical telomere length in human cells (Q40073766) (← links)
- Identification of HLA-DR1- and HLA-DR15-restricted human papillomavirus type 16 (HPV16) and HPV18 E6 epitopes recognized by CD4 T cells from healthy young women. (Q40148614) (← links)
- T-cell receptor tetramer binding or the lack there of does not necessitate antigen reactivity in T-cell receptor transduced T cells. (Q40336672) (← links)
- Cross-typic specificity and immunotherapeutic potential of a human HPV16 E7-specific CTL line. (Q40478974) (← links)
- Systemic listeriosis following vaccination with the attenuated Listeria monocytogenes therapeutic vaccine, ADXS11-001 (Q41619256) (← links)
- Individual variation in the frequency of HLA class II-specific cytotoxic T lymphocyte precursors. (Q41739364) (← links)
- Expression of CD200 on AML blasts directly suppresses memory T-cell function. (Q42572899) (← links)
- Increased CD200 expression in acute myeloid leukemia is linked with an increased frequency of FoxP3 regulatory T cells. (Q42572959) (← links)
- A recombinant vaccinia virus encoding human papillomavirus types 16 and 18, E6 and E7 proteins as immunotherapy for cervical cancer. (Q45769906) (← links)
- Immunological responses in women with human papillomavirus type 16 (HPV-16)-associated anogenital intraepithelial neoplasia induced by heterologous prime-boost HPV-16 oncogene vaccination (Q47637442) (← links)
- Epitope specificity and longevity of a vaccine-induced human T cell response against HPV18. (Q48956742) (← links)
- Expansion of a CD8( )PD-1( ) replicative senescence phenotype in early stage CLL patients is associated with inverted CD4:CD8 ratios and disease progression. (Q50977009) (← links)
- Activity, safety, and feasibility of cidofovir and imiquimod for treatment of vulval intraepithelial neoplasia (RT³VIN): a multicentre, open-label, randomised, phase 2 trial (Q51107636) (← links)
- Promiscuous behavior of HPV16E6 specific T cell receptor beta chains hampers functional expression in TCR transgenic T cells, which can be restored in part by genetic modification. (Q55031696) (← links)
- Human cancer vaccines (Q60193081) (← links)
- Sensitivity to inhibition of DNA repair by Olaparib in novel oropharyngeal cancer cell lines infected with Human Papillomavirus (Q60302619) (← links)
- T-cell response to human papillomavirus type 52 L1, E6, and E7 peptides in women with transient infection, cervical intraepithelial neoplasia, and invasive cancer (Q61700525) (← links)
- Cytotoxic T cells head for the clinic? (Q73621950) (← links)
- The use of human leucocyte antigen class I transgenic mice to investigate human immune function (Q77813558) (← links)
- Anti-viral cytotoxic T cells inhibit the growth of cancer cells with antibody targeted HLA class I/peptide complexes in SCID mice (Q77839439) (← links)
- Activated B cells mediate efficient expansion of rare antigen-specific T cells (Q79829633) (← links)
- Definition of an HPV18/45 cross-reactive human T-cell epitope after DNA immunisation of HLA-A2/KB transgenic mice (Q81624591) (← links)
- The immunosuppressive ligands PD-L1 and CD200 are linked in AML T-cell immunosuppression: identification of a new immunotherapeutic synapse (Q86883798) (← links)
- Increased frequency of CD4 PD-1 HLA-DR T cells is associated with disease progression in CLL (Q91183940) (← links)
- Chronic lymphocytic leukaemia: the role of T cells in a B cell disease (Q92837570) (← links)
- Use of an anti-CD200-blocking antibody improves immune responses to AML in vitro and in vivo (Q100388437) (← links)